atherosclerosis, normo-cholesterol adults with coronary disease, other occlusive arterial disease, or diabetes
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2002 Jul 6;360(9326):7-22 Randomized Controlled Trial, Multicenter Study
IN atherosclerosis, normo-cholesterol adults with coronary disease, other occlusive arterial disease, or diabetes The Use of
statins, simvastatin, for 5 years
As -
Is better Than
placebo
To reduce coronary death rate (5.7% intv. / 6.9% cont.) and all-cause mortality (12.9% intv. / 14.7% cont.). Reduce major vascular events after the first year.